XENE - Xenon Pharmaceuticals Summary, Stock Quote and News | Benzinga

Market Overview

14.00 -0.65 (-4.44%)

Data as of Dec 11, 2019

Prev. Close 14.65
Price Open 14.65
Volume 33,200
Day's Range 13.9 - 14.65
52 Wk Range 5.41 - 14.95
50 Day Moving Avg. 9.71
PE Ratio 0
Shares Outstanding 25.88M
Market Cap 362.32M

Trade XENE stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint Shanthi RexalineWed, 11 Dec 2019 07:21:31 -0500
Stocks That Hit 52-Week Highs On Tuesday Lisa LevinTue, 10 Dec 2019 14:27:17 -0500
Xenon Pharmaceuticals Provides Updates on Partnered Neurology Pipeline Programs at AES 2019 Charles GrossSat, 07 Dec 2019 14:56:00 -0500
50 Stocks Moving In Thursday's Mid-Day Session Lisa LevinThu, 05 Dec 2019 12:07:53 -0500
The Daily Biotech Pulse: Aurinia Rips Higher On Positive Readout, Sesen Bio On Track For Vicinium BLA Submission Shanthi RexalineThu, 05 Dec 2019 07:14:16 -0500
Stocks That Hit 52-Week Highs On Wednesday Lisa LevinWed, 04 Dec 2019 10:30:36 -0500
The Daily Biotech Pulse: Roche's Tecentriq Snags FDA Nod For Lung Cancer, Rapt Out-Licenses Cancer Drug Shanthi RexalineWed, 04 Dec 2019 07:06:30 -0500
63 Biggest Movers From Yesterday Lisa LevinWed, 04 Dec 2019 05:15:28 -0500
The Daily Biotech Pulse: Astellas To Buy Audentes For $3B, Applied Genetics Chief Medical Officer Quits, Axsome Aces Midstage Trial Shanthi RexalineTue, 03 Dec 2019 07:59:26 -0500
44 Stocks Moving In Monday's Mid-Day Session Lisa LevinMon, 02 Dec 2019 12:11:02 -0500
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Xenon Pharmaceuticals Provides Updates on Partnered Neurology Pipeline Programs at the 2019 American Epilepsy Society (AES) Annual Meeting Globe Newswire4 days ago
Xenon Pharmaceuticals Provides Updates on Proprietary Neurology Pipeline Programs at the 2019 American Epilepsy Society (AES) Annual Meeting Globe Newswire5 days ago
Xenon Pharmaceuticals to Present at the 31st Annual Piper Jaffray Healthcare Conference Globe NewswireDec 03, 2019
Xenon Pharmaceuticals to Host Conference Call and Webcast to Provide Corporate Update on License and Collaboration Agreement with Neurocrine Biosciences Globe NewswireDec 02, 2019
Neurocrine Biosciences and Xenon Pharmaceuticals Announce Agreement to Develop First-in-Class Treatments for Epilepsy Globe NewswireDec 02, 2019
Neurocrine Biosciences and Xenon Pharmaceuticals Announce Agreement to Develop First-in-Class Treatments for Epilepsy PRNewswireDec 02, 2019
Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences Globe NewswireNov 15, 2019
Xenon Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update Globe NewswireNov 05, 2019
Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2019 Financial Results and Provide Corporate Update Globe NewswireOct 29, 2019
Encode Ideas, L.P. Announces the Initiation of Research Coverage on Xenon Pharmaceuticals Inc. NewsfileOct 16, 2019
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Xenon Pharmaceuticals Provides Updates on Partnered Neurology Pipeline Programs at the ... GuruFocus3 days ago
Xenon Pharmaceuticals Provides Updates on Proprietary Neurology Pipeline Programs at the ... GuruFocus4 days ago
Xenon Pharmaceuticals (XENE) Investor Presentation - Slideshow Seeking Alpha5 days ago
Neurocrine Partners With Xenon To Add New Early-Stage Pipeline Assets Seeking Alpha5 days ago
SKT, CLVS among premarket gainers Seeking AlphaDec 02, 2019
Xenon Pharma up 23% premarket on Neurocrine Bio partnership in epilepsy Seeking AlphaDec 02, 2019
Xenon Pharmaceuticals to Host Conference Call and Webcast to Provide Corporate Update on ... GuruFocusDec 02, 2019
Retailers, Dubai Airshow And Cybertrucks (Stocks To Watch Podcast) Seeking AlphaNov 17, 2019
Stocks To Watch: Retailers, Dubai Airshow And Cybertrucks Seeking AlphaNov 16, 2019
Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences GuruFocusNov 15, 2019
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Powered by StockSnips

76.11% Positive

Earnings View Earnings

Q3 2019	EST	Actual	Surprise
EPS:	-0.480	-0.330	0.1500
Rev:		3.50M

Q4 2019	EST	Actual	Surprise
EPS:	Expected 2020-03-04
Rev:	Expected 2020-03-04

Company Profile

Read More

Brokerage Center

Compare All Online Brokerages

Book A Demo

Learn How You Can Succeed In The Market With Benzinga Pro

Fastest Market News

Real-Time News Alerts

Customizable News Filters

Book A Demo